Bio-Gene Technology Limited is an Australian biotechnology company focused on developing and commercializing next-generation bio-insecticides to address global challenges such as insecticide resistance and environmental toxicity. The company’s proprietary platforms, Flavocide and Qcide, are based on naturally occurring compounds that offer effective pest control with minimal impact on human health and ecosystems. Bio-Gene’s business model centers on licensing its technology to insect control companies and generating revenue through upfront payments, milestones, and royalties, as well as supplying active ingredients for commercial products. Headquartered in Melbourne and founded in 1995, Bio-Gene Technology Limited operates in the agtech and biotechnology sectors, targeting the growing demand for sustainable agricultural solutions. The company is listed on the CHI-X Market Australia - Limit Venue, providing investors access to its innovative approach to pest management and environmental stewardship.